NCT05997992 Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder
| NCT ID | NCT05997992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
| Condition | Overactive Bladder |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-01-11 |
| Primary Completion | 2023-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-01-11 with a primary completion date of 2023-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Overactive bladder (OAB) is often accompanied by frequent urination and nocturia, and does not necessarily manifest as urge incontinence. Urgency to urinate and frequent urination can lead to psychological burdens, affect interpersonal relationships and reduce women's quality of life. Treatment of OAB includes lifestyle changes, behavioral therapy, drug therapy, neuromodulation, botulinum toxin therapy, and surgical intervention. At present, anticholinergic drugs are usually the first-line treatment for OAB, but the side effects of dry mouth often lead to poor patient compliance. Transcutaneous tibial nerve stimulation (PTNS) is a minimally invasive neuromodulation technique. Past studies have confirmed that PTNS has clinical efficacy in treating symptoms related to overactive bladder, while TCM's electroacupuncture is similar to PTNS. The main purpose of this study was to evaluate the specific acupoints in accordance with traditional Chinese medicine theory in women with OAB under conventional Western medicine treatment to evaluate the improvement of women's related urinary tract symptoms, quality of life and autonomic nervous system function.
Eligibility Criteria
Inclusion Criteria: * Female patient aged 20-80 with overactive bladder. Exclusion Criteria: * Patient has history of cancer, stroke, or hyperthyroidism.. * Patient isn't willing to accept acupuncture or moxibustion treatment. * Patient who is pregnant or plan to pregnant. * Patient with urinary tract infection. * Patient who had injection of botulinum toxin (Botox®), PTNS or SMN treatment before. * Patient recieved acupuncture treatment before.
Frequently Asked Questions
Who can join the NCT05997992 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 80 Years, studying Overactive Bladder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05997992 currently recruiting?
Yes, NCT05997992 is actively recruiting participants. Visit ClinicalTrials.gov or contact Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation to inquire about joining.
Where is the NCT05997992 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT05997992 clinical trial?
NCT05997992 is sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. The trial plans to enroll 100 participants.